Companies Dominating the Pneumonia Testing Landscape
- Abbott
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Quidel Corporation
- Thermo Fisher Scientific Inc.
- bioMérieux SA
- INTEC
- OpGen
- BD (Becton, Dickinson, and Company)
- Meridian Bioscience, Inc.
- Luminex Corporation (DiaSorin S.p.A.)
- F. Hoffmann-La Roche Ltd.
Browse Key Market Insights with Data Illustration:
In the News
-
bioMérieux, a global leader in invitro diagnostics, unveils that it has reached an agreement to procure Specific Diagnostics, a privately held American Company that has created a rapid antimicrobial susceptibility test (AST) system that provides phenotypic AST directly from positive blood cultures.
-
A corporation among DiaSorin (FTSE MIB: DIA) and B.R.A.H.M.S. GmbH, a division of Thermo Fisher Scientific, has been formed with the goal of developing and marketing the novel LIAISON B.R.A.H.M.S MR-proADM immunodiagnostic test. The test can assist in the detection of several serious illnesses, including sepsis, septic shock, lower respiratory infections, urinary tract infections, and kidney disease.
